Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912156550> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2912156550 abstract "Purpose The use of atypical antipsychotic (AAP) medications in the pediatric population is increasing. Only one AAP recently received FDA approval (Risperdal, October 2006) for use in children with autism and disruptive behavior; otherwise, use of AAP medications in children is “off-label.” Data supporting safety and effectiveness in pediatrics are quite limited. Our purpose was to assess the prevalence and growth pattern of AAP use in the pediatric Medicaid population in Arkansas. Methods Pharmacy claims data for Arkansas Medicaid recipients filling an AAP prescription between January 2000 and June 2006 were analyzed. The population was controlled for continuous Medicaid benefit eligibility. The results are descriptive analyses of aggregate AAP prescribing patterns for roughly half of all Arkansas children. Results Between January 2000 and June 2006, there was a 5.4-fold increase in raw number of prescriptions written for AAP to patients under the age of 18. By January 2005, prescriptions to pediatric patients for AAP had surpassed the number of prescriptions written for adults, and in June 2006, pediatric patients represented 53% of the total AAP prescribed that month. Prevalence calculations were made controlling for continuous Medicaid benefit eligibility. The data revealed doubling of the rate of use of AAPs in children since 2000. Conclusions The use of AAP medicines in children enrolled in Medicaid/ARKids has increased at an alarming rate. This has occurred despite limited research to support the use of AAP in pediatrics and no FDA approval for the use of any AAP in pediatrics for the time frame of this study. Although the FDA recently approved the use of one AAP with autism, Medicaid-eligible children in Arkansas are prescribed AAP medicines more often than the recently reported prevalence of autism (1 in 166 in the pediatric population, or 0.6%). For children between the ages of 5 and 18, roughly 2 of every 100 children eligible for Medicaid in Arkansas are receiving prescriptions for an AAP medication." @default.
- W2912156550 created "2019-02-21" @default.
- W2912156550 creator A5038449504 @default.
- W2912156550 creator A5039950223 @default.
- W2912156550 creator A5067178333 @default.
- W2912156550 creator A5072787281 @default.
- W2912156550 date "2007-01-01" @default.
- W2912156550 modified "2023-09-23" @default.
- W2912156550 title "314 PATTERNS OF ATYPICAL ANTIPSYCHOTIC USE IN CHILDREN IN ARKANSAS." @default.
- W2912156550 hasPublicationYear "2007" @default.
- W2912156550 type Work @default.
- W2912156550 sameAs 2912156550 @default.
- W2912156550 citedByCount "0" @default.
- W2912156550 crossrefType "journal-article" @default.
- W2912156550 hasAuthorship W2912156550A5038449504 @default.
- W2912156550 hasAuthorship W2912156550A5039950223 @default.
- W2912156550 hasAuthorship W2912156550A5067178333 @default.
- W2912156550 hasAuthorship W2912156550A5072787281 @default.
- W2912156550 hasConcept C104863432 @default.
- W2912156550 hasConcept C105795698 @default.
- W2912156550 hasConcept C160735492 @default.
- W2912156550 hasConcept C162324750 @default.
- W2912156550 hasConcept C187212893 @default.
- W2912156550 hasConcept C2426938 @default.
- W2912156550 hasConcept C2776534028 @default.
- W2912156550 hasConcept C2908647359 @default.
- W2912156550 hasConcept C33923547 @default.
- W2912156550 hasConcept C39896193 @default.
- W2912156550 hasConcept C50522688 @default.
- W2912156550 hasConcept C512399662 @default.
- W2912156550 hasConcept C71924100 @default.
- W2912156550 hasConcept C98274493 @default.
- W2912156550 hasConcept C99454951 @default.
- W2912156550 hasConceptScore W2912156550C104863432 @default.
- W2912156550 hasConceptScore W2912156550C105795698 @default.
- W2912156550 hasConceptScore W2912156550C160735492 @default.
- W2912156550 hasConceptScore W2912156550C162324750 @default.
- W2912156550 hasConceptScore W2912156550C187212893 @default.
- W2912156550 hasConceptScore W2912156550C2426938 @default.
- W2912156550 hasConceptScore W2912156550C2776534028 @default.
- W2912156550 hasConceptScore W2912156550C2908647359 @default.
- W2912156550 hasConceptScore W2912156550C33923547 @default.
- W2912156550 hasConceptScore W2912156550C39896193 @default.
- W2912156550 hasConceptScore W2912156550C50522688 @default.
- W2912156550 hasConceptScore W2912156550C512399662 @default.
- W2912156550 hasConceptScore W2912156550C71924100 @default.
- W2912156550 hasConceptScore W2912156550C98274493 @default.
- W2912156550 hasConceptScore W2912156550C99454951 @default.
- W2912156550 hasIssue "1" @default.
- W2912156550 hasLocation W29121565501 @default.
- W2912156550 hasOpenAccess W2912156550 @default.
- W2912156550 hasPrimaryLocation W29121565501 @default.
- W2912156550 hasRelatedWork W1967885027 @default.
- W2912156550 hasRelatedWork W1973802256 @default.
- W2912156550 hasRelatedWork W1982072286 @default.
- W2912156550 hasRelatedWork W2012923862 @default.
- W2912156550 hasRelatedWork W2029263339 @default.
- W2912156550 hasRelatedWork W2037002800 @default.
- W2912156550 hasRelatedWork W2063452698 @default.
- W2912156550 hasRelatedWork W2066359129 @default.
- W2912156550 hasRelatedWork W2105761955 @default.
- W2912156550 hasRelatedWork W2107673798 @default.
- W2912156550 hasRelatedWork W2116044625 @default.
- W2912156550 hasRelatedWork W2160485564 @default.
- W2912156550 hasRelatedWork W2170904362 @default.
- W2912156550 hasRelatedWork W2187057644 @default.
- W2912156550 hasRelatedWork W2351564920 @default.
- W2912156550 hasRelatedWork W2778573170 @default.
- W2912156550 hasRelatedWork W2943960764 @default.
- W2912156550 hasRelatedWork W3172818164 @default.
- W2912156550 hasRelatedWork W3186060800 @default.
- W2912156550 hasRelatedWork W340096 @default.
- W2912156550 hasVolume "55" @default.
- W2912156550 isParatext "false" @default.
- W2912156550 isRetracted "false" @default.
- W2912156550 magId "2912156550" @default.
- W2912156550 workType "article" @default.